高级检索
当前位置: 首页 > 详情页

Comparisons of the Safety of Hydromorphone Hydrochloride Solution for Patient Controlled Analgesia When Prepared Under Hospital Ward and Pharmacy Intravenous Admixture Services Environments

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [1]Hebei Med Univ, Hosp 4, Dept Pharm, Shijiazhuang 050011, Hebei, Peoples R China [2]Hebei Med Univ, Hosp 4, Hebei Inst Drug & Med Device Control, Shijiazhuang 050011, Hebei, Peoples R China [3]Hebei Med Univ, Hosp 4, Library , Shijiazhuang 050011, Hebei, Peoples R China [4]Hebei Med Univ, Shijiazhuang 050017, Hebei, Peoples R China
出处:
ISSN:

关键词: Hydromorphone hydrochloride patient controlled analgesia pump pharmacy intravenous admixture service microbial contamination

摘要:
To determine the safety of hydromorphone hydrochloride solution for long term use in patient controlled analgesia by comparing the microbial contamination of preparations made under hospital ward dispensing room and pharmacy intravenous admixture service operating environment. Hydromorphone hydrochloride solutions were prepared in the patient controlled analgesia pump using 0.9 % sodium chloride under ward dispensing room or pharmacy intravenous admixture service operating environments. The solutions were stored at 25 degrees and 37 degrees and inspected for clarity and tested for bacterial endotoxin contamination for 15 d. The hydromorphone hydrochloride solution prepared under the ward dispensing room remained clear and endotoxin levels were below detection limits for 9 d. On d 11, this solution appeared turbid with slightly increased bacterial endotoxin levels. No remarkable observations were noted in the solution prepared under the pharmacy intravenous admixture service environment for the duration of the experiment. Hydromorphone hydrochloride solution prepared under the ward dispensing room conditions remained safe for use for only 9 d after preparation. On the other hand, the solution prepared under pharmacy intravenous admixture service remained suitable for use for longer as no contamination was observed for the duration of the study.

语种:
WOS:
中科院分区:
出版当年[2021]版:
大类 | 4 区 医学
小类 | 4 区 药学
最新[2025]版:
JCR分区:
出版当年[2021]版:
Q4 PHARMACOLOGY & PHARMACY
最新[2023]版:
Q4 PHARMACOLOGY & PHARMACY

影响因子: 最新[2023版] 最新五年平均 出版当年[2021版] 出版当年五年平均 出版前一年[2020版] 出版后一年[2022版]

第一作者:
第一作者机构: [1]Hebei Med Univ, Hosp 4, Dept Pharm, Shijiazhuang 050011, Hebei, Peoples R China
通讯作者:
通讯机构: [1]Hebei Med Univ, Hosp 4, Dept Pharm, Shijiazhuang 050011, Hebei, Peoples R China [*1]Department of Pharmacy, The Fourth Hospital of Hebei Medical University
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:39770 今日访问量:0 总访问量:1333 更新日期:2025-05-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 河北医科大学第四医院 技术支持:重庆聚合科技有限公司 地址:河北省石家庄市健康路12号